photocreo-michal-bednarek-shutterstock-com

PHOTOCREO Michal Bednarek / Shutterstock.com

13 August 2015Peter Pitts

Why biopharma patents should be free from PTAB clutches

The UK’s pharmaceutical industry reportedly employs more than 70,000 workers and in 2013 contributed around £13 billion ($20.2 billion) to the economy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Unified Patent Court: The cases, the numbers and what the future holds

Second chances: Brazil’s bid to revitalise the country’s healthcare system

Why the US non-competes ban has riled Big Pharma

Life sciences cases at the UPC will surely rise, but is the court prepared?

Moderna’s COVID-19 pledge dilemma

Crafting a claim for AI in medtech: Two case studies

Overcoming the challenges of US patent eligibility for nature-based elements